Role of drug transport and metabolism in the chemoresistance of acute myeloid leukemia

Blood Reviews
J J G MarinRocio I R Macias

Abstract

Acute myeloid leukemia is a clonal but heterogeneous disease differing in molecular pathogenesis, clinical features and response to chemotherapy. This latter frequently consists of a combination of cytarabine and anthracyclines, although etoposide, demethylating agents, and other drugs are also used. Unfortunately, chemoresistance is a common and serious problem. Multiple mechanisms account for impaired effectiveness of drugs and reduced levels of active agents in target cells. The latter can be due to lower drug uptake, increased export or decreased intracellular proportion of active/inactive agent due to changes in the expression/function of enzymes responsible for the activation of pro-drugs and the inactivation of active agents. Characterization of the "resistome", or profile of expressed genes accounting for multi-drug resistance (MDR) phenotype, would permit to predict the lack of response to chemotherapy and would help in the selection of the best pharmacological regime for each patient and moment, and to develop strategies of chemosensitization.

References

Feb 1, 1982·The Journal of Clinical Investigation·J S WileyA R Paterson
Nov 6, 1998·Trends in Pharmacological Sciences·M Pastor-AngladaF J Casado
May 15, 2002·Leukemia Research·Carlos M GalmariniCharles Dumontet
Aug 3, 2002·Leukemia & Lymphoma·Dorina M van der KolkEdo Vellenga
Nov 2, 2002·Blood·Míriam Molina-ArcasMarçal Pastor-Anglada
Jul 3, 2003·Pflügers Archiv : European journal of physiology·Stephen A BaldwinJames D Young
Jul 12, 2003·Pflügers Archiv : European journal of physiology·Jennifer H GrayKathleen M Giacomini
Mar 11, 2004·Blood Reviews·Krzysztof MrózekClara D Bloomfield
Dec 9, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Zineb BenderraOllivier Legrand
May 19, 2005·Cancer Research·Natasha Y FrankMarkus H Frank
Nov 10, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Zineb BenderraOllivier Legrand
Feb 4, 2006·Blood·Frederick R AppelbaumStephen H Petersdorf
Jul 22, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Daniel SteinbachThomas Efferth
Aug 25, 2006·Molecular Cancer Therapeutics·Thomas EfferthDaniel Steinbach
Jun 26, 2007·Blood Cells, Molecules & Diseases·Robert HinesDong-Er Zhang
Jan 15, 2009·International Journal of Cancer. Journal International Du Cancer·Lena OevermannChristoph A Ritter
Feb 26, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Yanping GuoMarkus Schaich
Apr 28, 2009·Leukemia Research·Gustav LehneOla Myklebost
Sep 25, 2009·The New England Journal of Medicine·Bob LöwenbergUNKNOWN Swiss Group for Clinical Cancer Research (SAKK) Collaborative Group
Sep 25, 2009·The New England Journal of Medicine·Hugo F FernandezMartin S Tallman
Oct 22, 2009·Pharmacogenomics·Jatinder K Lamba

❮ Previous
Next ❯

Citations

Jan 4, 2018·International Journal of Cancer. Journal International Du Cancer·Sameer SalunkheShilpee Dutt
Oct 12, 2017·Expert Opinion on Pharmacotherapy·Tracy Murphy, Karen W L Yee
Jun 20, 2018·The Journal of Immunology : Official Journal of the American Association of Immunologists·Rosalie M SternerKaren E Hedin
Dec 28, 2019·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Pietro CarotenutoChiara Braconi
Jun 3, 2021·International Journal of Molecular Sciences·Guadalupe Rosario Fajardo-OrduñaEdelmiro Santiago-Osorio
Nov 9, 2019·Journal of Medicinal Chemistry·John G WisePia D Vogel

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.